| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.061 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |